Health

Variants in the genome interact with each other and with the environment to affect risk of cardiovascular disease

REYKJAVIK, Iceland, Sept. 14, 2023 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from the Icelandic healthcare system and TheCopenhagen University, publish a study today in the journal Cell titled "Complex effects of sequence variants on lipid level...

2023-09-14 23:00 2303

Foundry Mixer Healthcare, Indonesian Minister of Health Budi G. Sadikin: "Together We Leapfrog Indonesia's Healthcare Transformation"

Indonesian Minister of Health, Budi Gunadi Sadikin, emphasized that investing in the Health Technology and Biotechnology sector serves not only business prospects but also strengthens Indonesia's health resilience and adds value to healthcare. JAKARTA, Indonesia, Sept. 14, 2023 /PRNewswire/ -- F...

2023-09-14 17:47 1683

Break the cycle of dehydration and skin sensitivity with the NEW Cetaphil® Optimal Hydration Skin Replenishing Water Gel

The NEW Cetaphil Skin Replenishing Water Gel is clinically proven to provide 72-hour hydration with its slow-release technology containing Hyaluronic Acid and Polyglutamic Acid KUALA LUMPUR, Malaysia, Sept. 14, 2023 /PRNewswire/ -- Cetaphil®, the #1 dermatological skincare brand inMalaysia intro...

2023-09-14 17:17 1891

Neoss® Group launches NeoTell™ a new device to measure implant stability.

ZÜRICH, Sept. 14, 2023 /PRNewswire/ -- Earlier this year, Neoss Group, a pioneer in dental implant solutions, announced a partnership with Osstell AB, a global leader in implant stability measurement and osseointegration progress monitoring. Today, we proudly introduce the first fruit of this col...

2023-09-14 16:00 1643

Two Affiliated Hospitals Unveiled Simultaneously, Neusoft Education Exerts Efforts In a New Ecosystem Of Healthcare Technology Education

HONG KONG, Sept. 14, 2023 /PRNewswire/ -- On the morning of September 14, the unveiling ceremony of Dalian Neusoft University of Information's affiliated Cardiovascular Hospital and affiliated Stomatological Hospital was held at the phase II square of the provincial-level university science and t...

2023-09-14 13:53 4848

Innovative Collaboration: Buzzreach and Oncoshot Spearhead Clinical Trial Advancements in Japan

SINGAPORE, Sept. 14, 2023 /PRNewswire/ -- Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials inJapan. The former specialises in clinical trial site recruitment and retention and project managemen...

2023-09-14 10:00 2544

MGI and Bio-Medical Science Sign MOU to Deliver Cutting-Edge Sequencing Platforms and Reagents to South Korea

CHEONAN, South Korea, 14 September 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions inSouth Korea by leveraging MGI's cutting-edge technology. The M...

2023-09-14 09:00 1848

Avasa raises $1.55M in oversubscribed funding round with innovative implantable devices

MIAMI and AUCKLAND, New Zealand, Sept. 14, 2023 /PRNewswire/ -- Avasa, a medical device pioneer advancing surgical techniques for improved patient outcomes, announces the successful completion of its recent funding, raising an impressive$1.55 million in capital investment. The influx of new inves...

2023-09-14 04:50 1981

AWAK TECHNOLOGIES RAISES US$20+ MILLION, READYING ITS WEARABLE DIALYSIS DEVICE FOR US-BASED PIVOTAL TRIAL

* AWAK closes one of the largest MedTech fundraise in 2023 in Southeast Asia * The Series B round was co-led by new investor Lion X Ventures and long-term investor Vickers Venture Partners, along with other new and existing investors * AWAK's ultra-portable peritoneal dialysis system enables ...

2023-09-13 21:27 2491

Exelixis and Insilico Medicine Enter into Exclusive Global License Agreement for ISM3091, a Potentially Best-in-Class USP1 Inhibitor

— ISM3091 is a highly selective, orally bioavailable small molecule inhibitor of USP1  identified through Insilico Medicine's artificial intelligence (AI) platform, with potent activity in BRCA-mutated tumor models — — In May 2023, the U.S. Food and Drug Administration (FDA) cleared Insilico's I...

2023-09-13 20:29 1956

Global Times: Witness to history: Chinese people in Morocco share life-and-death earthquake experiences, rush to assist locals to get through disaster

BEIJING, Sept. 13, 2023 /PRNewswire/ -- At 1.28 am, obstetrician Zhang Qian finally heard the loud cry of a baby. It was a healthy baby girl. Zhang breathed a sigh of relief performing after a nerve-racking hour-long C-section on a Moroccan patient. While in surgery at a Moroccan hospital, Zhang ...

2023-09-13 19:48 1619

91% of doctors in Southeast Asia participate in digital learning despite societal return to in-person interactions - Docquity

* Docquity survey shows that doctor attendance at digital learning events is higher than in-person events (at 3.9 versus 3.0 times per month) * While two learning cohorts have emerged - digital dominant learners and in-person dominant learners, both groups participate in digital learning yet ...

2023-09-13 10:55 749

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

SINGAPORE, Sept. 13, 2023 /PRNewswire/ -- Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development, manufacturing and commercialization of the orally administered Janus kinase (JAK) inhibitor Smyraf® 50 mg and 100 ...

2023-09-13 10:30 2605

Maxigen Biotech Inc. Wins 2023 Asia's Leading SMEs Award for Innovative Sustainability

KUALA LUMPUR, Malaysia, Sept. 13, 2023 /PRNewswire/ -- Maxigen Biotech Inc.(MBI), a pioneering biotech company headquartered inTaiwan, has been honored with the prestigious 2023 Asia's Leading SMEs Award by ACES underscoring its commitment to innovation and sustainable operations.

2023-09-13 09:30 2147

"Promoting Health, Wellness, and Community: Gowalking.com Unites Global Fitness Walkers for a Better World"

BOCA RATON, Fla., Sept. 12, 2023 /PRNewswire/ -- Today marks the launch of Gowalking.com, a groundbreaking start-up founded byJeremy Goldstein, with a mission to connect and empower the world's estimated 1.2 billion fitness walkers by providing a simple and innovative platform for finding and joi...

2023-09-12 22:30 2904

Frost & Sullivan Recognizes Suki AI with the 2023 North American Technology Leadership Award

Suki's innovative AI Assistant brings the power of Generative AI to health systems and delivers strong ROI SAN ANTONIO, Sept. 12, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare voice assistant industry and, based on its findings, recognizesSuki AI with the 2023 North Am...

2023-09-12 22:00 1845

TMRW Life Sciences Receives CE Mark for the CryoRobot Select, its Next-Generation Automated Platform to Safely Manage and Store Frozen Eggs and Embryos

TMRW's Cutting-Edge Technology is Raising the Standard of Care in Global Fertility NEW YORK, Sept. 12, 2023 /PRNewswire/ -- TMRW Life Sciences, a fertility technology company automating the IVF lab, today announced that it has received a CE Mark for the CryoRobot Select (CRS). The European desig...

2023-09-12 21:01 1741

CSafe Expands Executive Team with Chief Financial Officer

Seasoned financial leader, Anthony Pishotti, joins CSafe executive team to further drive the company's portfolio and geographic growth. MONROE, Ohio, Sept. 12, 2023 /PRNewswire/ -- CSafe, the largest active and passive temperature-controlled shipping solutions provider for the biopharmaceutical ...

2023-09-12 20:59 2186

Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media

News Summary: * Updated Waters™ OneLab™ software creates new, easy-to-use walk-up solutions integrating Waters BioAccord™ LC-MS system and Andrew+™ robot with upstream bioreactors to automate routine product quality and cell culture media analyses. * New pre-developed LC-MS analytical workflow...

2023-09-12 20:00 1867

New South Wales Government (NSW) Partner, Myeloid Therapeutics, Initiates Patient Dosing with MT-302 in Phase 1 Study at Clinical Site in Australia

NSW and Myeloid entered into a partnership in February 2023 to launch state-of-the-art GMP manufacturing RNA facility CAMBRIDGE, Mass., Sept. 12, 2023 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage oncology company, has dosed the first patient with MT-302 in a Phase 1 s...

2023-09-12 20:00 1092
1 ... 125126127128129130131 ... 582